Name | 4H-Furo[3,4-d]imidazol-4-one, 3,6-dihydro-6,6-dimethyl-2-propyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]- 4-yl]methyl]- |
Synonyms | Olmesartan impuirty B Olmesartan Related Compound A Olmesartan Lactone Impurity A Olmesartan MedoxomiI Impurity B Olmesartan Medoxomil EP Impurity B, RNH-6352 3,6-Dihydro-6,6-dimethyl-2-propyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-furo[3,4-d]imidazol-4-one 3-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6,6-dimethyl-2-propyl-3,6-dihydro-4H-furo[3,4-d]imidazol-4-one 4H-Furo[3,4-d]imidazol-4-one, 3,6-dihydro-6,6-dimethyl-2-propyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]- 4-yl]methyl]- |
CAS | 849206-43-5 |
Molecular Formula | C24H24N6O2 |
Molar Mass | 428.49 |
Density | 1.35±0.1 g/cm3(Predicted) |
Melting Point | 173 - 175°C (Subl.) |
Boling Point | 701.6±70.0 °C(Predicted) |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Appearance | Solid |
Color | White to Off-White |
pKa | 4.16±0.10(Predicted) |
Storage Condition | Refrigerator |
HS Code | 2934990002 |